Mohit Kaushal
CIK 1683021 · last filed 2026-07-29
Mohit Kaushal is a corporate insider who has filed 24 SEC Form 4 insider transactions across 6 companies since 2016. The most recent filing, for TOI, was dated Jul 29, 2026. Across all open-market trades the lifetime net is −$393.0K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TOIIW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WHITE PLAINS, NY 10601
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. (TOI) Delisted | Director | 205,716 | $5.13 | $1.06M | $0 | 4 | 2026-07-29 |
| Oncology Institute, Inc. (TOIIW) Delisted | Director | 211,016 | $0.05 | $10.3K | -$393.0K | 8 | 2026-04-16 |
| Oak Street Health, Inc. (OSH) Delisted | Director | 0 | $39.00 | $0 | $0 | 7 | 2023-05-02 |
| AdaptHealth Corp. (AHCOW) Delisted | Director | 20,000 | — | — | $0 | 1 | 2019-11-13 |
| AdaptHealth Corp. (VTL) Delisted | Director | 652 | — | — | $0 | 1 | 2018-04-03 |
| UNIVERSAL AMERICAN CORP. (UAM) Delisted | Director | 10,430 | — | — | $0 | 1 | 2016-12-08 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-29 | Oncology Institute, Inc. (TOI) Delisted | Grant (A) | +33,133 | $0 | EDGAR |
| 2026-04-16 | Oncology Institute, Inc. (TOIIW) Delisted | Sell (S) | −95,719 | -$335.1K | EDGAR |
| 2026-04-14 | Oncology Institute, Inc. (TOI) Delisted | Notice (144) | −95,719 | -$315.9K | EDGAR |
| 2025-11-24 | Oncology Institute, Inc. (TOIIW) Delisted | Grant (A) | +91,049 | $0 | EDGAR |
| 2024-11-25 | Oncology Institute, Inc. (TOIIW) Delisted | Grant (A) | +56,000 | $0 | EDGAR |
| 2023-12-28 | Oncology Institute, Inc. (TOIIW) Delisted | Grant (A) | +53,326 | $0 | EDGAR |
| 2023-05-02 | Oak Street Health, Inc. (OSH) Delisted | Disp (D) | −215,224 | -$8.39M | EDGAR |
| 2023-04-25 | Oak Street Health, Inc. (OSH) Delisted | Grant (A) | +5,140 | $0 | EDGAR |
| 2023-03-21 | Oncology Institute, Inc. (TOIIW) Delisted | Grant (A) | +19,685 | $0 | EDGAR |
| 2022-11-21 | Oncology Institute, Inc. (TOIIW) Delisted | Grant (A) | +22,708 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.